Cell Death Discovery,
Journal Year:
2023,
Volume and Issue:
9(1)
Published: July 28, 2023
Neural
progenitor
cells
(NPCs)
of
the
subventricular
zone
proliferate
in
response
to
ischemic
stroke
adult
mouse
brain.
Newly
generated
have
been
considered
influence
recovery
following
a
stroke.
However,
mechanism
underlying
such
protection
is
matter
active
study
since
it
has
thought
that
proliferating
NPCs
mediate
their
protective
effects
by
secreting
soluble
factors
promote
rather
than
neuronal
replacement
penumbra.
We
tested
hypothesis
this
mediated
secretion
multimolecular
complexes
extracellular
vesicles
(EVs).
found
molecular
oxygen
and
glucose-deprived
(OGD)
NPCs-derived
EVs
very
limited
improving
overt
neurological
alterations
caused
compared
our
recently
reported
astrocyte-derived
EVs.
when
we
inhibited
ischemia-triggered
proliferation
with
chronic
administration
DNA
synthesis
inhibitor
Ara-C,
effect
NPC-derived
became
evident,
suggesting
endogenous
exerted
NPC
mainly
carried
out
through
involves
intercellular
communication
analyzed
proteomic
content
cargo
label-free
relative
abundance
mass
spectrometry
identified
several
mediators
within
these
vesicles.
Our
findings
indicate
are
against
cascade
activated
and,
thus,
hold
significant
therapeutic
potential.
World Journal of Stem Cells,
Journal Year:
2021,
Volume and Issue:
13(8), P. 1030 - 1048
Published: Aug. 19, 2021
Inflammation
plays
an
important
role
in
the
pathological
process
of
ischemic
stroke,
and
systemic
inflammation
affects
patient
prognosis.
As
resident
immune
cells
brain,
microglia
are
significantly
involved
defense
tissue
repair
under
various
conditions,
including
cerebral
ischemia.
Although
differentiation
M1
M2
is
certainly
oversimplified,
changing
activation
state
appears
to
be
intriguing
therapeutic
strategy
for
Recent
evidence
indicates
that
both
mesenchymal
stem
(MSCs)
MSC-derived
extracellular
vesicles
(EVs)
regulate
modify
preclinical
stroke
conditions.
However,
precise
mechanisms
these
signaling
pathways,
especially
context
mutual
interaction
between
MSCs
or
EVs
microglia,
have
not
been
sufficiently
unveiled.
Hence,
this
review
summarizes
state-of-the-art
knowledge
on
MSC-
MSC-EV-mediated
regulation
microglial
activity
conditions
with
respect
cytokines,
neurotrophic
factors,
transcription
microRNAs.
Frontiers in Neurology,
Journal Year:
2022,
Volume and Issue:
13
Published: Nov. 8, 2022
Stroke,
a
cerebrovascular
accident,
is
prevalent
and
the
second
highest
cause
of
death
globally
across
patient
populations;
it
as
significant
morbidity
mortality.
Mesenchymal
stem
cell
(MSC)
transplantation
emerging
promising
treatment
for
alleviating
neurological
deficits,
indicated
by
great
number
animal
clinical
studies.
The
potential
regulating
immune
system
currently
being
explored
therapeutic
target
after
ischemic
stroke.
This
study
will
discuss
recent
evidence
that
MSCs
can
harness
interacting
with
cells
to
boost
neurologic
recovery
effectively.
Moreover,
notion
be
given
participating
in
multiple
pathological
processes,
such
increasing
survival
angiogenesis
suppressing
apoptosis
autophagy
several
phases
stroke,
consequently
promoting
function
recovery.
We
conclude
review
highlighting
opportunities
reviewing
safety,
feasibility,
efficacy
therapy.
Stem Cell Research & Therapy,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: April 3, 2023
Abstract
Background
Extracellular
vesicles
derived
from
stem
cells
(SC-EVs)
have
been
proposed
as
a
novel
therapy
for
ischemic
stroke.
However,
their
effects
remain
incompletely
understood.
Therefore,
we
conducted
this
meta-analysis
to
systematically
review
the
efficacy
of
SC-EVs
on
stroke
in
preclinical
rodent
models.
Methods
Using
PubMed,
EMBASE,
and
Web
Science,
searched
through
studies
published
up
August
2021
that
investigated
treatment
model.
Infarct
volume
was
primary
outcome.
Neurological
severity
scores
(mNSS)
were
secondary
The
standard
mean
difference
(SMD)
confidence
interval
(CI)
calculated
using
random-effects
R
Stata
15.1
used
conduct
meta-analysis.
Results
Twenty-one
2015
met
inclusion
criteria.
We
also
found
SCs-EVs
reduced
infarct
by
an
SMD
−
2.05
(95%
CI
2.70,
1.40;
P
<
0.001).
Meanwhile,
our
results
revealed
overall
positive
effect
SCs-derived
EVs
mNSS
with
1.42
1.75,
1.08;
Significant
heterogeneity
among
observed.
Further
stratified
sensitivity
analyses
did
not
identify
source
heterogeneity.
Conclusion
present
confirmed
SC-EV
could
improve
neuron
function
reduce
model,
providing
helpful
clues
human
clinical
trials
SC-EVs.
World Journal of Stem Cells,
Journal Year:
2023,
Volume and Issue:
15(6), P. 561 - 575
Published: June 26, 2023
The
high
incidence
and
disability
rates
of
stroke
pose
a
heavy
burden
on
society.
Inflammation
is
significant
pathological
reaction
that
occurs
after
an
ischemic
stroke.
Currently,
therapeutic
methods,
except
for
intravenous
thrombolysis
vascular
thrombectomy,
have
limited
time
windows.
Mesenchymal
stem
cells
(MSCs)
can
migrate,
differentiate,
inhibit
inflammatory
immune
responses.
Exosomes
(Exos),
which
are
secretory
vesicles,
the
characteristics
from
they
derived,
making
them
attractive
targets
research
in
recent
years.
MSC-derived
exosomes
attenuate
response
caused
by
cerebral
modulating
damage-associated
molecular
patterns.
In
this
review,
mechanisms
associated
with
Exos
therapy
injury
discussed
to
provide
new
approach
clinical
treatment.
Cell Death Discovery,
Journal Year:
2023,
Volume and Issue:
9(1)
Published: July 28, 2023
Neural
progenitor
cells
(NPCs)
of
the
subventricular
zone
proliferate
in
response
to
ischemic
stroke
adult
mouse
brain.
Newly
generated
have
been
considered
influence
recovery
following
a
stroke.
However,
mechanism
underlying
such
protection
is
matter
active
study
since
it
has
thought
that
proliferating
NPCs
mediate
their
protective
effects
by
secreting
soluble
factors
promote
rather
than
neuronal
replacement
penumbra.
We
tested
hypothesis
this
mediated
secretion
multimolecular
complexes
extracellular
vesicles
(EVs).
found
molecular
oxygen
and
glucose-deprived
(OGD)
NPCs-derived
EVs
very
limited
improving
overt
neurological
alterations
caused
compared
our
recently
reported
astrocyte-derived
EVs.
when
we
inhibited
ischemia-triggered
proliferation
with
chronic
administration
DNA
synthesis
inhibitor
Ara-C,
effect
NPC-derived
became
evident,
suggesting
endogenous
exerted
NPC
mainly
carried
out
through
involves
intercellular
communication
analyzed
proteomic
content
cargo
label-free
relative
abundance
mass
spectrometry
identified
several
mediators
within
these
vesicles.
Our
findings
indicate
are
against
cascade
activated
and,
thus,
hold
significant
therapeutic
potential.